major hypertriglyceridemia
ORPHA: 1814251 Treatment Available
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Mipomersen Orphan Cold Chain | Subcutaneous injection, 200 mg/mL | FDA Approved | 1 | — |
Classification & Codes
Orphanet Code
ORPHA:181425major hypertriglyceridemia
| Orphanet | ORPHA:181425 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO